[HTML][HTML] Modulation of intracellular copper levels as the mechanism of action of anticancer copper complexes: Clinical relevance

MV Babak, D Ahn - Biomedicines, 2021 - mdpi.com
Copper (Cu) is a vital element required for cellular growth and development; however, even
slight changes in its homeostasis might lead to severe toxicity and deleterious medical …

Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids

K Nepali, S Sharma, M Sharma, PMS Bedi… - European journal of …, 2014 - Elsevier
A Hybrid drug which comprises the incorporation of two drug pharmacophores in one single
molecule are basically designed to interact with multiple targets or to amplify its effect …

Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents

GL Beretta, G Cassinelli, M Pennati, V Zuco… - European journal of …, 2017 - Elsevier
Resistance to conventional and target specific antitumor drugs still remains one of the major
cause of treatment failure and patience death. This condition often involves ATP-binding …

[HTML][HTML] Metal-and metalloid-based compounds to target and reverse cancer multidrug resistance

A Valente, A Podolski-Renić, I Poetsch… - Drug Resistance …, 2021 - Elsevier
Drug resistance remains the major cause of cancer treatment failure especially at the late
stage of the disease. However, based on their versatile chemistry, metal and metalloid …

Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition

KM Hanssen, M Haber, JI Fletcher - Drug Resistance Updates, 2021 - Elsevier
Resistance to chemotherapy remains one of the most significant obstacles to successful
cancer treatment. While inhibiting drug efflux mediated by ATP-binding cassette (ABC) …

Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands

WDJ Tremlett, DM Goodman, TR Steel, S Kumar… - Coordination chemistry …, 2021 - Elsevier
The small molecule anticancer agent cisplatin and its Pt (II) analogs carboplatin and
oxaliplatin are widely used to treat a variety of tumorigenic diseases. Despite their structural …

Anticancer thiosemicarbazones: chemical properties, interaction with iron metabolism, and resistance development

FS PapeVeronika, A EnyedyÉva… - Antioxidants & redox …, 2019 - liebertpub.com
Significance: During the past decades, thiosemicarbazones were clinically developed for a
variety of diseases, including tuberculosis, viral infections, malaria, and cancer. With regard …

Targeting Multidrug Resistance Protein 1 (MRP1, ABCC1): Past, Present, and Future

SPC Cole - Annual review of pharmacology and toxicology, 2014 - annualreviews.org
The human ATP-binding cassette transporter multidrug resistance protein 1 (MRP1),
encoded by ABCC1, was initially identified because of its ability to confer multidrug …

Collateral sensitivity as a strategy against cancer multidrug resistance

KM Pluchino, MD Hall, AS Goldsborough… - Drug Resistance …, 2012 - Elsevier
While chemotherapy remains the most effective treatment for disseminated tumors, acquired
or intrinsic drug resistance accounts for approximately 90% of treatment failure. Multidrug …

[HTML][HTML] Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance

G Szakács, MD Hall, MM Gottesman… - Chemical …, 2014 - ACS Publications
The development of multidrug resistance (MDR) in patients suffering cancer remains a
significant clinical challenge, with drug efflux by ABC (ATP-binding cassette) transporters …